Skip to main content
SpringerLink
Log in

The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Although prostate-specific antigen (PSA) is the most valuable tumor marker for the diagnosis and management of prostate carcinoma, it is widely accepted that PSA is not prostate specific. Numerous studies have shown that PSA is present in some female hormonally regulated tissues, principally the breast and its secretions. In this review, we summarize the findings of PSA in the breast, and focus on its potential for clinical applications in breast disease. PSA is produced by the majority of breast tumors and is a favorable indicator of prognosis in breast cancer. Low levels of PSA are released into the female circulation, and while the level of serum PSA is elevated in both benign and malignant breast disease, the molecular form of circulating PSA differs between women with and without breast cancer. These findings indicate that PSA may have potential diagnostic utility in breast cancer. PSA may also have a clinical application in benign breast disease, as both the level and molecular form of PSA differ between Type I and II breast cysts. High levels of PSA have been reported in nipple aspirate fluid (NAF) and recent studies have shown that the concentration of PSA in NAF is inversely related to breast cancer risk, indicating that NAF PSA may represent a clinical tool for breast cancer risk assessment. Thus, PSA represents a marker with numerous potential clinical applications as a diagnostic and/or prognostic tool in breast disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Riegman PHJ, Vlietstra RJ, Suurmeijer L, Cleutjens CBJM, Trapman J: Characterization of the human kallikrein locus. Genomics 14: 6-11, 1992

    Google Scholar 

  2. Clements JA: The human kallikrein gene family: a diversity of expression and function. Mol Cell Endocrinol 99: C1-6, 1994

    Google Scholar 

  3. Yousef GM, Luo L-Y, Diamandis EP: Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4. Anticancer Res (in press)

  4. Dube JY: Tissue kallikreins and prostatic diseases in man: new questions. Biochem Cell Biol 70: 177-178, 1992

    Google Scholar 

  5. Deperthes D, Marceau F, Frenette G, Lazure C, Tremblay RR, Dube JY: Human kallikrein hK2 has low kininogenase activity while prostate-specific antigen (hK3) has none. Biochim Biophys Acta 1343: 102-106, 1997

    Google Scholar 

  6. MacDonald RJ, Margolius HS, Erdos EG:Molecular biology of tissue kallikrein. Biochem J 253: 313-321, 1988

    Google Scholar 

  7. Berg T, Bradshaw RA, Carretero OA, Chao J, Chao L, Clements JA, Fahnestock M, Fritz H, Gauthier F, MacDonald RJ: A common nomenclature for members of the tissue (glandular) kallikrein gene families. Recent progress on kinins. Agents Actions 38 (suppl 1): 19-25, 1992

    Google Scholar 

  8. Fukushima D, Kitamura N, Nakanishi S: Nucleotide sequence of cloned cDNA for human pancreatic kallikrein. Biochemistry 24: 8037-8043, 1985

    Google Scholar 

  9. Schedlich LJ, Bennetts BH, Morris BJ: Primary structure of a human glandular kallikrein gene. DNA 6: 429-437, 1987

    Google Scholar 

  10. Chapdelaine P, Paradis G, Tremblay RR, Dube JY: High level expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen. FEBS Lett 236: 205-208, 1988

    Google Scholar 

  11. Kumar A, Mikolajczyc SD, Goel AS, Millar LS, Saedi MS: Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res 57: 3111-3114, 1997

    Google Scholar 

  12. Lovgren J, Rajakoski K, Karp M, Lundwall A, Lilja H: Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Biochem Biophys Res Comm 238: 549-555, 1997

    Google Scholar 

  13. Takayama TK, Fujikawa K, Davie EW: Characterization of the precursor of prostate-specific antigen. J Biol Chem 272: 21582-21588, 1997

    Google Scholar 

  14. Watt KW, Lee PJL, M'Timkulu TM, Chan WP, Loor R: Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc Natl Acad Sci USA 83: 3166-3170, 1986

    Google Scholar 

  15. Akiyama K, Nakamura T, Iwanaga S, Hara M: The chymotrypsin-like activity of human prostate-specific antigen, g-seminoprotein. FEBS Lett 225: 168-172, 1987

    Google Scholar 

  16. Frankel AE, Rouse RV, Wang MC, Chu TM, Herzenber LA: Monoclonal antibody to a human prostate antigen. Cancer Res 42: 3714-3718, 1982

    Google Scholar 

  17. Sinha AA, Wilson MJ, Gleason DF: Immunoelectron microscopic localization of prostate-specific antigen in human prostate by the Protein A-gold complex. Cancer 60: 1288-1293, 1987

    Google Scholar 

  18. Sensabaugh GF: Isolation and characterization of a semenspecific protein from human seminal plasma: A potential new marker for semen identification. J Forensic Sci 23: 106-115, 1978

    Google Scholar 

  19. Lilja H, Oldbring J, Rannevik G, Laurell C-B: Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. J Clin Invest 80: 281-285, 1993

    Google Scholar 

  20. Ohlsson K, Bjartell A, Lilja H: Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization. J Androl 16: 64-74, 1995

    Google Scholar 

  21. Christensson A, Laurell CB, Lilja H: Enzymatic activity of the prostate-specific antigen and its reactions with extracellular serine protease inhibitors. Eur J Biochem 194: 755-763, 1990

    Google Scholar 

  22. Kuriyama M, WangMC, Papsidero LD, Killian CS, Shimano T, Valenzuela L, Nishiura T, Murphy GP, Chu T: Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res 40: 4658-4662, 1980

    Google Scholar 

  23. Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Pettersson K, Lovgren T: Prostate-specific antigen in human serum occurs predominantly in a complex with a1-antichymotrypsin. Clin Chem 37: 1618-1625, 1991

    Google Scholar 

  24. Lilja H: Regulation of the enzymatic activity of prostatespecific antigen and its reactions with extracellular protease inhibitors in prostate cancer. Scand J Clin Lab Invest Supp 220: 45-56, 1995

    Google Scholar 

  25. Mikolajczyk SD, Grauer LS, Millar LS, Hill TM, Kumar A, Rittenhouse HG, Wolfert RL, Saedi MS: A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum. Urology 50: 710-714, 1997

    Google Scholar 

  26. Noldus J, Chen Z, Stamey TA: Isolation and characterization of free form prostate-specific antigen (f-PSA) in sera of men with prostate cancer. J Urol 158: 1606-1609, 1997

    Google Scholar 

  27. Papsidero LD, Wang MC, Valenzuela LA, Murphy GP, Chu TM: A prostate antigen in sera of prostatic cancer patients. Cancer Res 40: 2428-2432, 1980

    Google Scholar 

  28. Montie JE and Meyers SE: Defining the ideal tumor marker for prostate cancer. Urol Clin N Am 24: 247-252, 1997

    Google Scholar 

  29. Armbruster DA: Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin Chem 39: 181-195, 1993

    Google Scholar 

  30. Yu H, Diamandis EP: Ultrasensitive time-resolved immuno-fluorometric assay of prostate-specific antigen in serum and preliminary clinical studies. Clin Chem 39: 2108-2114, 1993

    Google Scholar 

  31. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostatespecific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226, 1991

    Google Scholar 

  32. Partin AW, Kelly CA, Subong ENP, Walsh PC, Chan DW, Wang TJ, Rittenhouse HG, Wolfert RL, Norton KC, Mc-Cormack R: Measurement of the ratio of free PSA to total improves prostate cancer detection for men with total PSA levels between 4 and 10 ng/mL. J Urol 153: 295A, 1995

    Google Scholar 

  33. Young CY, Seay T, Hogen K, Charlesworth MC, Roche PC, Klee GG, Tindall DJ: Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer. Prostate Suppl 7: 17-24, 1996

    Google Scholar 

  34. Charlesworth MC, Young CY, Klee GG, Saedi MS, Mikolajczyk SD, Finlay JA, Tindall DJ: Detection of a prostatespecific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels. Urology 49: 487-493, 1997

    Google Scholar 

  35. Black MH, Magklara A, Obiezu CV, Melegos DN, Wolfert RL, Diamandis EP: Development of an ultrasensitive immunoassay for human glandular kallikrein with no crossreactivity with prostate-specific antigen. Clin Chem 45: 790-799, 1999

    Google Scholar 

  36. Klee GG, Goodmanson MK, Jacobson SJ, Young CY, Finlay JA, Rittenhouse HG, Wolfert RL, Tindall DJ: Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2. Clin Chem 45: 800-806, 1999

    Google Scholar 

  37. Stenman U-H: New ultrasensitive assays facilitate studies on the role of human glandular kallikrein (hK2) as a marker for prostatic disease. Clin Chem 45: 753-754, 1999

    Google Scholar 

  38. Pollen JJ and Dreilinger A: Immunohistochemical identi-fication of prostatic acid phosphatase and prostate-specific antigen in female periurethral glands. Urology 23: 303-304, 1984

    Google Scholar 

  39. Tepper SL, Jagirdar J, Heath D, Geller SA: Homology between the female paraurethral (Skene's) glands and the prostate. Immuno-histochemical demonstration. Arch Pathol Lab Med 108: 423-425, 1984

    Google Scholar 

  40. Wernert N, Albrech M, Sesterhenn I, Goebbels R, Bonkhoff H, Seitz G, Inniger R, Remberger K: The 'female prostate'. Location, morphology, immunohistochemical characteristics and significance. Eur Urol 22: 64-69, 1992

    Google Scholar 

  41. Svanholm H, Andersen OP, Rohl H: Tumour of female paraurethral duct. Immunohistochemical similarity with prostatic carcinoma. Virchowas Arch A Pathol Anat Histopathol 411: 395-398, 1987

    Google Scholar 

  42. Spencer JR, Brodin AG, Ignatoff JM: Clear cell adenocarcinoma of the urethra: evidence for origin within paraurethral ducts. J Urol 143: 122-125, 1990

    Google Scholar 

  43. Zaviacic M, Sidlo J, Borovsky M: Prostate-specific antigen and prostate-specific acid phosphatase in adenocarcinoma of Skene's paraurethral glands and ducts. Virchows Arch 423: 503-505, 1993

    Google Scholar 

  44. Ebisuno S, Miyai M, Tomofumi N: Clear cell adenocarcinoma of the female urethra showing positive staining with antibodies to prostate-specific antigen and prostatic acid phosphatase. Urology 45: 682-685, 1995

    Google Scholar 

  45. Papotti M, Paties C, Peveri V, Moscuzza L, Bussolati G: Immunocytochemical detection of prostate-specific antigen (PSA) in skin and breast tissues and tumours. Basic Appl Histochem 33: 25-29, 1989

    Google Scholar 

  46. Golz R, Schubert GE: Prostatic specific antigen. Immunoreactivity in urachal remnants. J Urol 141: 1480-1482, 1989

    Google Scholar 

  47. Minkowittz G, Peterson P, Godwin TA: A histochemical and immunohistochemical study of adenocarcinomas involving urinary bladder. Mod Pathol 3: 68A, 1990

    Google Scholar 

  48. Grignon DJ, Ro JY, Ayala AG, Johnson DE, Ordonez NG: Primary adenocarcinoma of the urinary bladder: a clinicopathologic analysis of 72 cases. Cancer 67: 2165-2172, 1991

    Google Scholar 

  49. Ishikawa T, Kashiwagi H, Iwakami Y, Hirai M, Kawamura T, Aiyoshi Y, Yashiro T, Ami Y, Uchida K, Miwa M: Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction. Jpn J Clin Oncol 28: 723-728, 1998

    Google Scholar 

  50. Kamoshida S, Tsutsumi Y: Extraprostatic localization of prostatic acid phosphatase and prostate-specific antigen: distribution in cloacogenic glandular epithelium and sexdependent expression in human anal gland. Hum Pathol 21: 1108-1111, 1990

    Google Scholar 

  51. McLachlin SM, Srigley JR: Prostatic tissue in mature cystic teratomas of the ovary. Am J Surg Pathol 16: 780-784, 1992

    Google Scholar 

  52. Buzzi A, Crescini C, Sonzogni A, Pezzica E: Prostatic tissue in a cystic teratoma of the ovary. Minerva Ginecol 46: 49-51, 1994

    Google Scholar 

  53. Frazier HA, Humphrey PA, Burchette JL, Paulson DF: Immunoreactive prostate-specific antigen in male periurethral glands. J Urol 147: 246-248, 1992

    Google Scholar 

  54. van Krieken JH: Prostate marker immunoreactivity in salivary gland neoplasm. A rare pitfall in immunohistochemistry. Am J Surg Pathol 17: 410-414, 1993

    Google Scholar 

  55. James GK, Pudek M, Berean DW, Diamandis EP: Salivary duct carcinoma secreting prostate-specific antigen. AmJ Clin Pathol 106: 242-247, 1996

    Google Scholar 

  56. Elgamal AA, van de Voorde W, van Poppel H, Leuweryns J, Baert L: Immunohistochemical localization of prostatespecific markers within the accessory male sex gland of Cowper, Littre, and Morgagni. Urology 44: 84-90, 1994

    Google Scholar 

  57. Diamandis EP, Yu H, Sutherland DJA: Detection of prostatespecific antigen immunoreactivity in breast tumours. Breast Cancer Res Treat 32: 301-310, 1994

    Google Scholar 

  58. Monne M, Croce CM, Yu H, Diamandis EP: Molecular characterization of prostate-specific antigen mRNA expressed in breast tumors. Cancer Res 54: 6344-6347, 1994

    Google Scholar 

  59. Yu H, Diamandis EP, Sutherland DJA: Immunoreactive prostate-specific antigen levels in female and male breast tumours and its association with steroid hormone receptors and patient age. Clin Biochem 27: 75-79, 1994

    Google Scholar 

  60. Wu JT, Zhang ME, Wilson LW, Lyons BW, Wu LL, Stephenson R: PSA immunoreactivity detected in LNCaP cell medium, breast tumor cytosol, and female serum. J Clin Lab Anal 9: 243-251, 1995

    Google Scholar 

  61. Filella X, Molina R, Alcover J, Menendez V, Gimenez N, Jo J, Carretero P, Ballesta AM: Prostate-specific antigen detection by ultrasensitive assay in samples from women. Prostate 29: 311-316, 1996

    Google Scholar 

  62. Yu H, Diamandis EP, Levesque M, Giai M, Roagna R, Ponzone R, Sismondi P, Monne M, Croce C: Prostatespecific antigen in breast cancer, benign breast disease and normal breast tissue. Breast Cancer Res Treat 40: 171-178, 1996

    Google Scholar 

  63. Zarghami N, Diamandis EP: Detection of prostate-specific antigen mRNA and protein in breast tumours. Clin Chem 42: 361-366, 1996

    Google Scholar 

  64. Bodey B, Bodey B Jr, Kaiser HE: Immunocytochemical detection of prostate-specific antigen expression in human breast carcinoma cells. Anticancer Res 17: 2577-2582, 1997

    Google Scholar 

  65. Howarth DJC, Aronson IB, Diamandis EP: Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues. Br J Cancer 75: 1646-1651, 1997

    Google Scholar 

  66. Alanen KA, Kuopio T, Koskinen PJ, Nevalainen TJ: Immunohistochemical labeling for prostate-specific antigen in non-prostatic tissues. Path Res Pract 192: 233-237, 1996

    Google Scholar 

  67. Clements JA, Mukhtar A: Glandular kallikreins and prostatespecific antigen are expressed in the human endometrium. J Clin Endocrinol Metab 78: 1536-1539, 1994

    Google Scholar 

  68. Sleater JP, Ford MJ, Beers BB: Extra-mammary Paget's disease associated with prostate carcinoma. Hum Pathol 25: 615-617, 1994

    Google Scholar 

  69. Levesque M, Yu H, D'Costa M, Diamandis EP: Prostatespecific antigen expression by various tumors. J Clin Lab Anal 9: 123-128, 1995

    Google Scholar 

  70. Yu H, Diamandis EP: Prostate-specific antigen reactivity in amniotic fluid. Clin Chem 41: 204-210, 1995

    Google Scholar 

  71. Filella X, Molina R, Alcover J, Carretero P, Ballesta AM: Detection of nonprostatic PSA in serum and non-serum samples from women. Int J Cancer 68: 424-427, 1996

    Google Scholar 

  72. Melegos DN, Yu H, Allen LC, Diamandis EP: Prostatespecific antigen in amniotic fluid of normal and abnormal pregnancies. Clin Chem 29: 555-562, 1996

    Google Scholar 

  73. Smith MR, Biggar S, Hussain M: Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res 55: 2640-2644, 1995

    Google Scholar 

  74. Yu H, Diamandis EP, Monne M, Croce C: Oral contraceptiveinduced expression of prostate-specific antigen in the female breast. J Biol Chem 270: 6615-6618, 1995

    Google Scholar 

  75. Levesque M, Yu H, D'Costa M, Tadross L, Diamandis EP: Immunoreactive prostate-specific antigen in lung tumours. J Clin Lab Anal 9: 375-379, 1995

    Google Scholar 

  76. Zarghami N, D'Costa M, Tsuyuki D, Asa SL, Diamandis EP: Expression of the prostate-specific antigen gene by lung tissue. Clin Cancer Res 3: 1201-1206, 1997

    Google Scholar 

  77. Zarghami N, Levesque M, D'Costa M, Angelopoulou K, Diamandis EP: Frequency of expression of prostate-specific antigen mRNA in lung tumours. Am J Clin Pathol 108: 184-190, 1997

    Google Scholar 

  78. Yu H, Diamandis EP: Prostatic-specific antigen in milk of lactating women. Clin Chem 41: 54-58, 1995

    Google Scholar 

  79. Yu H, Diamandis EP, Levesque M, Asa S, Monne M, Croce CM: Expression of the prostate-specific antigen gene by a primary ovarian carcinoma. Cancer Res 55: 1603-1606, 1995

    Google Scholar 

  80. Kuopio T, Ekfors TO, Nikkanen V, Nevalainen TJ: Acinar cell carcinoma of the pancreas: report of three cases. APMIS 103: 69-78, 1995

    Google Scholar 

  81. Giai M, Yu H, Roagna R, Ponzone R, Katsaros D, Levesque MA, Diamandis EP: Prostate-specific antigen in serum of women with breast cancer. Br J Cancer 72: 728-731, 1995

    Google Scholar 

  82. Lehrer S, Terk M, Piccoli SP, Song HK, Lavagnini P, Luderer AA: Reverse transcriptase-polymerase chain reaction for prostate-specific antigen may be a prognostic indicator in breast cancer. Br J Cancer 74: 871-873, 1996

    Google Scholar 

  83. Melegos DN, Diamandis EP: Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer. Clin Biochem 29: 193-200, 1996

    Google Scholar 

  84. Borchert GH, Melegos DN, Tomlinson G, Giai M, Roagna R, Ponzone R, Sgro L, Diamandis EP: Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases. Br J Cancer 76: 1087-1094, 1997

    Google Scholar 

  85. Black MH, Giai M, Ponzone R, Sismondi P, Yu H, Diamandis EP: Serum total and free prostate-specific antigen for breast cancer diagnosis in women. Clin Cancer Res (in press)

  86. Yu H, Diamandis EP: Measurement of serum prostatespecific antigen levels in females and in prostatectomized males with an ultrasensitive immunoassay technique. J Urol 153: 1004-1008, 1995

    Google Scholar 

  87. Mannello F, Bianchi G, Gazzanelli G: Immunoreactivity of prostate-specific antigen in plasma and saliva of healthy women. Clin Chem 42: 1110-1111, 1996

    Google Scholar 

  88. Zarghami N, Grass L, Sauter ER, Diamandis EP: Prostatespecific antigen levels in serum during the menstrual cycle. Clin Chem 43: 1862-1867, 1997

    Google Scholar 

  89. Melegos DN and Diamandis EP: Is prostate-specific antigen present in female serum? Clin Chem 44: 691-692, 1998

    Google Scholar 

  90. Diamandis EP, Yu H, Lopez-Otin C: Prostate-specific antigen-a new constituent of breast cyst fluid. Breast Cancer Res Treat 38: 259-264, 1996

    Google Scholar 

  91. Lai LC, Erbas H, Lennard TW, Peaston RT: Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer. Int J Cancer 66: 743-746, 1996

    Google Scholar 

  92. Mannello F, Bocchiotti G, Bianchi G, Marcheggiani F, Gazzanelli G: Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids. Breast Cancer Res Treat 38: 247-252, 1996

    Google Scholar 

  93. Borchert GH, Yu H, Tomlinson G, Giai M, Roagna R, Ponzone R, Sgro L, Diamandis EP: Prostate-specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease. J Clin Lab Anal 13: 75-81, 1999

    Google Scholar 

  94. Foretova L, Garber JE, Sadowsky NL, Verselis SJ, Li FP: Prostate-specific antigen in nipple aspirates. Lancet 347: 1631, 1996

    Google Scholar 

  95. Sauter ER, Daly M, Lenahan K, Ehya H, Engstrom PF, Sorling A, Bonney G, Yu H, Diamandis EP: Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev 5: 967-970, 1996

    Google Scholar 

  96. Sauter ER, Babb J, Daly M, Engstrom PF, Ehya H, Malick J, Diamandis EP: Prostate-specific antigen production in the female breast: association with progesterone. Cancer Epidemiol Biomarkers Prev 7: 315-320, 1998

    Google Scholar 

  97. Mannello F, Miragoli G, Bianchi G, Gazzanelli, G: Prostatespecific antigen in ascitic fluid. Clin Chem 43: 1461-1462, 1997

    Google Scholar 

  98. Melegos DN, Freedman MS, Diamandis EP: Prostatespecific antigen in cerebrospinal fluid. Clin Chem 43: 855, 1997

    Google Scholar 

  99. Mannello F, Miragoli G, Bianchi G, Gazzanelli G: Immunoreactive prostate-specific antigen in pleural effusions. Clin Chem 43: 847-848, 1997

    Google Scholar 

  100. Melegos DN, Yu H, Ashok M, Wang C, Stanczyk F, Diamandis EP: Prostate-specific antigen in female serum, a potential new marker for androgen excess. J Clin Endo Metab 82: 777-780, 1997

    Google Scholar 

  101. Mannello F, Malatesta M, Luchetti F, Papa S, Battistelli S, Gazzanelli G: Immunoreactivity, ultrastructural localization, and transcript expression of prostate-specific antigen in human neuroblastoma cell lines. Clin Chem 45: 78-84, 1999

    Google Scholar 

  102. Cleutjens KBJM, van der Korput HAGM, van Eekelen CCEM, van Rooij HCJ, Faber PW, Trapman J: An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostatespecific antigen promoter. Mol Endocrinol 11: 148-161, 1997

    Google Scholar 

  103. Beato M: Gene regulation by steroid hormones. Cell 56: 335-344, 1989

    Google Scholar 

  104. Shan J-D, Porvari K, Ruokonen M, Karhu A, Launonen V, Hedberg P, Oikarinen J, Vihko P: Steroid-involved transcriptional regulation of human genes encoding prostatic acid phosphatase, prostate-specific antigen, and prostate-specific glandular kallikrein. Endocrinol 138: 3764-3770, 1997

    Google Scholar 

  105. Zarghami N, Grass L, Diamandis EP: Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. Br J Cancer 75: 579-588, 1997

    Google Scholar 

  106. Killian CS, Corral DA, Kawinski E, Constantine RI: Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-b and a proteolytic modulation of cell adhesion receptors. Biochem Biophys Res Comm 192: 940-947, 1993

    Google Scholar 

  107. Yoshida E, Ohmura S, Sugiki M, Maruyama M, Mihara H: Prostate-specific antigen activates single-chain urokinasetype plasminogen activator. Int J Cancer 63: 863-865, 1995

    Google Scholar 

  108. Frenette G, Tremblay RR, Lazure C, Dube JY: Prostatic kallikrein hK2, but not prostate-specific antigen (hK3) activates single-chain urokinase-type plasminogen activator. Int J Cancer 71: 897-899, 1997

    Google Scholar 

  109. Webber MM, Waghray A, Bello D: Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin Cancer Res 1: 1089-1094, 1995

    Google Scholar 

  110. Cohen P, Peehl DM, Graves HCB, Rosenfeld RG: Biological effects of prostate-specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol 142: 407-415, 1994

    Google Scholar 

  111. Zaviacic M, Ablin RJ: The female prostate. J. Natl Cancer Inst 90: 713-714, 1998

    Google Scholar 

  112. Yu H, Levesque MA, Clark GM, Diamandis EP: Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study. Clin Cancer Res 4: 1489-1497, 1998

    Google Scholar 

  113. Tsuyuki D, Grass L, Diamandis EP: Frequent detection of mutations in the 50 flanking region of the prostate-specific antigen gene in female breast cancer. Eur J Cancer 33: 1851-1854, 1997

    Google Scholar 

  114. Majumdar S and Diamandis EP: The promoter and the enhancer region of the KLK3 (prostate-specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines. Br J Cancer 79: 1594-1602, 1999

    Google Scholar 

  115. Yu H, Diamandis EP, Zarghami N, Grass L: Induction of prostate-specific antigen production by steroids and tamoxifen in breast cancer cell lines. Br Cancer Res Treat 32: 291-300, 1994

    Google Scholar 

  116. Kogan I, Ballinger JR, Redshaw R, Diamandis EP, Melegos DN, Kuba RM, Rauth AM: Prostate-specific antigen induction by a steroid hormone in T47D cells growing in SCID mice. Breast Cancer Res Treat 48: 73-80, 1998

    Google Scholar 

  117. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJA, Levesque MA, Roagna R, Ponzone R, Sismondi P: Prostaticspecific antigen is a new favourable prognostic indicator for women with breast cancer. Cancer Res 55: 2104-2110, 1995

    Google Scholar 

  118. Hall RE, Clements JA, Birrell SN, Tilley WD. Prostatespecific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours. Br J Cancer 78: 360-365, 1998

    Google Scholar 

  119. Foekens JA, Diamandis EP, Yu H, Look MP, Meijer-van Gelder ME, van Putten WLJ, Klijn JGM: Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer. Br J Cancer 79: 888-894, 1999

    Google Scholar 

  120. Zangerle PF, Spyratos F, Le Doussal V, Noel G, Hacene K, Hendrick JC, Gest J, Franchimont P: Breast cyst fluid proteins and breast cancer. Ann NY Acad Sci 464: 331-349, 1986

    Google Scholar 

  121. Bradshaw HL, Fleishre M, Breed CN, Chasalow FI: Biochemical classification of patients with gross cystic breast disease. Ann NY Acad Sci 586: 12-16, 1990

    Google Scholar 

  122. Randell EW, Diamandis EP, Ellis G: Serum prostate-specific antigen measured in children from birth to age 18 years. Clin Chem 42: 420-423, 1996

    Google Scholar 

  123. Forest MG, Sizonenko PC, Cathiard AM, Bertrand J: Hypophysogonadal function in humans during the first year of life. J Clin Invest 53: 819-828, 1974

    Google Scholar 

  124. Katsaros D, Melegos DN, Diamandis EP: Prostate-specific antigen production by breast tumors after induction with oral contraceptives. Clin Biochem 31: 285-288, 1998

    Google Scholar 

  125. Diamandis EP, Helle SI, Yu H, Melegos DN, Lundgren S, Lonning PE: Prognostic value of plasma prostate-specific antigen following megestrol acetate treatment in patients with metastatic breast cancer. Cancer 85: 891-898, 1999

    Google Scholar 

  126. Black MH, Grass CL, Leinonen J, Stenman U-H, Diamandis EP: Characterization of monoclonal antibodies for prostatespecific antigen (PSA) and development of highly sensitive free PSA assays. Clin Chem 1999 45: 347-354, 1999

    Google Scholar 

  127. Lambert-Messerlian GM, Canick JA, Melegos DN, Diamandis EP: Increased concentrations of prostate-specific antigen in maternal serum from pregnancies affected by fetal Down Syndrome. Clin Chem 44: 205-208, 1998

    Google Scholar 

  128. Spencer K, Carpenter P: Is prostate-specific antigen a marker for pregnancies affected by Down syndrome? Clin Chem 44: 2362-2365, 1998

    Google Scholar 

  129. Reiss M, Barcellos-Hoff MH: Transforming growth factorbeta in breast cancer: a working hypothesis. Breast Cancer Res Treat 45: 81-95, 1997

    Google Scholar 

  130. Helle SI, Lonning PE: Insulin-like growth factors in breast cancer. Acta Oncol Supp 5: 19-22, 1996

    Google Scholar 

  131. Gill ZP, Perks CM, Newcomb PV, Holly JMP: Insulinlike growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. J Biol Chem 272: 25602-25607, 1997

    Google Scholar 

  132. Dauvois S, Geng CS, Levesque C, Merand Y, Labrie F: Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice. Cancer Res 51: 3131-3135, 1991

    Google Scholar 

  133. Balbay MD, Juang P, Llansa N, Williams S, McConkey D, Fidler IJ, Pettaway CA: Stable transfection of human prostate cancer cell line PC-3 with prostate-specific antigen induces apoptosis both in vivo and in vitro (Abstract). Proc Am Assoc Cancer Res 40: 225-226, 1999

    Google Scholar 

  134. Iwamura M, Hellman J, Cockett ATK, Lilja H, Gershagen S: Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen. Urology 48: 317-325, 1996

    Google Scholar 

  135. Wulf GG, Jurgens B, Liersch T, Gatzemeier W, Rauschecker H, Buske C, Hufner M, Hiddemann W, Wormann B: Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer. Cancer Res Clin Oncol 123: 514-521, 1997

    Google Scholar 

  136. Diamandis EP:....And secreted tumour suppressors. Nature Genet 13: 268, 1996

    Google Scholar 

  137. Rehbock J, Buchinger P, Hermann A, Figueroa C: Identification of immunoreactive tissue kallikrein in human ductal breast carcinomas. J Cancer Res Clin Oncol 121: 64-68, 1995

    Google Scholar 

  138. Hermann A, Buchinger P, Rehbock J: Visualization of tissue kallikrein in human breast carcinoma by two-dimensional western blotting and immunohistochemistry. Biol Chem Hoppe-Seyler 376: 365-370, 1995

    Google Scholar 

  139. Hsieh M-L, Charlesworth C, Goodmanson M, Zhang S, Seay T, Klee GG, Tindall DJ, Young CYF: Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D. Cancer Res 57: 2651-2656, 1997

    Google Scholar 

  140. Black MH, Magklara A, Obiezu CV, Levesque MA, Sutherland DJA, Tindall DJ, Young CYF, Sauter ER, Diamandis EP: Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions. Br J Cancer (in press)

  141. Magklara A, Scorilas A, Lopez-Otin C, Vizoso F, Ruibal A, Diamandis EP: Human glandular kallikrein (hK2) in breast milk, amniotic fluid, and breast cyst fluid. Clin Chem (in press)

  142. Liu XL, Wazer DE, Watanabe K, Band V: Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res 56: 3371-3379, 1996

    Google Scholar 

  143. Goyal J, Smith KM, Cowan JM, Wazer DE, Lee SW, Band V: The role for NES1 serine protease as a novel tumor suppressor. Cancer Res 58: 4782-4786, 1998

    Google Scholar 

  144. Parish DC: Prostate-specific antigen in the breast. Endo-Rel Cancer 5: 223-229, 1998

    Google Scholar 

  145. Lopez-Otin C, Diamandis EP: Breast and prostate cancer: An analysis of common epidemiological, genetic, and biochemical features. Endo Rev 19: 365-396, 1998

    Google Scholar 

  146. Diamandis EP, Yu H: Nonprosatic sources of prostatespecific antigen. Urol Clin N Am 24: 275-282, 1996

    Google Scholar 

Download references

Author information

Author notes

  1. Eleftherios P. Diamandis

    Present address: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Canada

    Margot H. Black & Eleftherios P. Diamandis

Authors
  1. Margot H. Black
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eleftherios P. Diamandis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Black, M.H., Diamandis, E.P. The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast. Breast Cancer Res Treat 59, 1–14 (2000). https://doi.org/10.1023/A:1006380306781

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006380306781

Search

Navigation